CORESPEC LTD

1. Financial Health Score: A-

Explanation: CORESPEC LTD has staged a remarkable recovery from a state of financial distress to one of robust health. Just five years ago, the company was technically insolvent with negative net assets and almost no cash. Today, it boasts a strong balance sheet, minimal long-term debt, and a significantly replenished cash reserve. The only reason this score falls just short of an A+ is the high concentration of wealth tied up in trade debtors (money owed by customers), which requires vigilant management to ensure it converts smoothly into cash.

2. Key Vital Signs

• Net Assets (The Patient's Constitution): £1,276,348 (up from £909,595 in 2024). Interpretation: This is a staggering recovery from the £-141,635 deficit recorded in 2020. The business has built substantial financial muscle and equity, meaning it is highly resilient to economic shocks.
• Cash at Bank (Blood Pressure): £276,872 (up from £20,337 in 2024). Interpretation: The company's financial circulation is vastly improved. In 2020, cash was a dangerously low £8,039. The current cash pile shows the business is generating strong liquidity and is no longer gasping for breath.
• Working Capital / Net Current Assets (The Immune System): £907,300. Interpretation: With current assets easily covering current liabilities (a current ratio of roughly 1.87:1), the company has a very strong immune system. It can comfortably fight off short-term financial obligations without needing external support.
• Liabilities (Cholesterol Levels): Total liabilities have dropped to £1,042,280, while long-term debt is a remarkably low £5,661. Interpretation: The company has cleared its arteries. The absence of heavy long-term bank debt means the business is self-funding and not weighed down by restrictive debt covenants or high interest payments.
• Trade Debtors (Digestion): £1,345,287. Interpretation: While having high sales is healthy, over £1.3 million owed by customers represents a slow digestion of revenue. If these debts age poorly, they could become toxic.

3. Diagnosis

The Patient's History: In 2020, CORESPEC LTD was in the financial equivalent of intensive care. With negative shareholder funds (-£142k) and a mere £8k in the bank, the business was technically insolvent and surviving on life support from its creditors.

The Recovery: Over the last five years, the company has undergone a dramatic rehabilitation. The P&L reserve has swung from a deficit to a £1.27 million surplus. The 2025 accounts show a profit injection of approximately £366k (the difference between the 2024 and 2025 P&L reserves), proving the core business model (manufacturing cardboard cores/paperboard) is highly profitable and generating real cash.

Current Condition: The patient is currently in excellent health. The recent investment in plant and machinery (£55,810 in additions) shows the company is reinvesting in its physical fitness to maintain operational efficiency. However, there is a symptom that requires monitoring: the high level of trade debtors (£1.34m) relative to trade creditors (£609k). The business is acting as a bank for its customers, funding their purchases for extended periods. While the cash position has surged, the business must ensure it is collecting what it is owed before it faces a cash flow blockage.

4. Recommendations

To maintain peak financial wellness and guard against future illness, I prescribe the following actions:

1. Prescribe a Strict Debtors Diet (Credit Control): With £1.34m tied up in trade debtors, you must ensure timely collection. Implement stricter credit terms, offer early payment discounts, and conduct regular health checks on your customers' creditworthiness. Do not let overdue invoices fester.
2. Maintain Cash Reserves (Vitamin Supplements): The jump from £20k to £276k in cash is excellent, but the 2024 dip shows how quickly cash can deplete. Keep a minimum cash buffer equivalent to 3 months of operating expenses to protect against any sudden market downturns.
3. Review Stock Levels (Metabolic Rate): Stock has increased from £189k to £257k. While this might be necessary for fulfilling orders, excess stock ties up working capital and risks obsolescence. Ensure inventory turnover remains efficient and that you aren't holding unnecessary dead stock.
4. Continue Capital Investment (Strength Training): The recent £55k investment in plant and machinery is a positive sign. Continue to invest in efficient machinery to maintain your competitive edge, utilizing your strong cash position rather than taking on expensive debt.